PreOmics is a company that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry.
PreOmics has raised €3.3M across 1 funding round from 1 investor, most recently a Series A round in Dec 2018. Based in Martinsried, Germany; founded 2016; active in Software. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-12-27 | Series A | €3.3M |
| Think.Health |
| View deal → |
